267 related articles for article (PubMed ID: 10989504)
1. [Viral superantigens].
Lafon M
Rev Med Interne; 2000 Aug; 21(8):713-6. PubMed ID: 10989504
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a viral superantigen in humans.
Lafon M; Lafage M; Martinez-Arends A; Ramirez R; Vuillier F; Charron D; Lotteau V; Scott-Algara D
Nature; 1992 Aug; 358(6386):507-10. PubMed ID: 1386410
[TBL] [Abstract][Full Text] [Related]
3. [Superantigens in human disease].
Rojas Ramos E; Cisneros González N; Cairo Cueto SM
Rev Alerg Mex; 1997; 44(3):77-82. PubMed ID: 9377117
[TBL] [Abstract][Full Text] [Related]
4. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
[TBL] [Abstract][Full Text] [Related]
5. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
6. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
7. The structural basis of T cell activation by superantigens.
Li H; Llera A; Malchiodi EL; Mariuzza RA
Annu Rev Immunol; 1999; 17():435-66. PubMed ID: 10358765
[TBL] [Abstract][Full Text] [Related]
8. Superantigens: structure and relevance to human disease.
Johnson HM; Torres BA; Soos JM
Proc Soc Exp Biol Med; 1996 Jun; 212(2):99-109. PubMed ID: 8650257
[TBL] [Abstract][Full Text] [Related]
9. [Superantigens and autoimmune diseases].
Kaneoka H; Naito S
Nihon Rinsho; 1997 Jun; 55(6):1363-9. PubMed ID: 9200919
[TBL] [Abstract][Full Text] [Related]
10. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
11. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
12. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
14. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
Modlin CS; Todd GT; Cohen TD; Fairchild RL
Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
[TBL] [Abstract][Full Text] [Related]
15. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
16. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of superantigens in human periodontal diseases: skewed expression of T cell receptor variable regions by gingival T cells.
Zadeh HH; Kreutzer DL
Oral Microbiol Immunol; 1996 Apr; 11(2):88-95. PubMed ID: 8941759
[TBL] [Abstract][Full Text] [Related]
18. MMTV superantigens coerce an unconventional topology between the TCR and MHC class II.
Fortin JS; Genève L; Gauthier C; Shoukry NH; Azar GA; Younes S; Yassine-Diab B; Sékaly RP; Fremont DH; Thibodeau J
J Immunol; 2014 Feb; 192(4):1896-906. PubMed ID: 24453254
[TBL] [Abstract][Full Text] [Related]
19. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
20. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.
Marrack P; Winslow GM; Choi Y; Scherer M; Pullen A; White J; Kappler JW
Immunol Rev; 1993 Feb; 131():79-92. PubMed ID: 8387458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
